ME
GEHC icon

McIlrath & Eck’s GE HealthCare GEHC Stock Holding History

McIlrath & Eck’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9K Buy
279
+16
+6% +$1.26K ﹤0.01% 825
2025
Q4 		$21.6K Buy
263
+78
+42% +$6.08K ﹤0.01% 496
2025
Q3 		$13.9K Buy
185
+50
+37% +$3.73K ﹤0.01% 574
2025
Q2 		$10K Sell
135
-50
-27% -$3.48K ﹤0.01% 598
2025
Q1 		$14.9K Buy
185
+25
+16% +$2.15K ﹤0.01% 528
2024
Q4 		$12.5K Sell
160
-76
-32% -$6.46K ﹤0.01% 583
2024
Q3 		$22.1K Hold
236
– – ﹤0.01% 458
2024
Q2 		$18.4K Sell
236
-10
-4% -$816 ﹤0.01% 478
2024
Q1 		$22.4K Buy
246
+3
+1% +$250 ﹤0.01% 433
2023
Q4 		$18.8K Sell
243
-3
-1% -$210 ﹤0.01% 425
2023
Q3 		$16.7K Sell
246
-16
-6% -$1.16K ﹤0.01% 438
2023
Q2 		$21.3K Sell
262
-16
-6% -$1.28K ﹤0.01% 408
2023
Q1 		$22.8K Buy
+278
New +$19.8K 0.01% 389

Other funds holding GEHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

McIlrath & Eck's GEHC Position: Q1 2026 in Review

McIlrath & Eck increased its GE HealthCare (GEHC) stake by 6.1% in Q1 2026, buying an estimated $1.26K and bringing the position to 279 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

McIlrath & Eck first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $22.8K in Q1 2023. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • McIlrath & Eck held 279 shares of GE HealthCare worth $19.9K as of Q1 2026.
  • McIlrath & Eck bought 16 GE HealthCare shares in Q1 2026, an estimated $1.26K.
  • GE HealthCare made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #825 holding.
  • McIlrath & Eck first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • McIlrath & Eck's GE HealthCare position peaked at $22.8K in Q1 2023.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.